Article Correctness Is Author's Responsibility: Patient groups untested in cancer immunotherapy trials found to also benefit

(Georgetown University Medical Center) Cancer patients previously excluded and underrepresented in immunotherapy clinical trials, such as African Americans and patients with HIV or viral hepatitis, actually benefit at the same rate as patients tested in the clinical trials, according to a Georgetown-led study to be presented at the 2019 ASCO Annual Meeting in Chicago.